Amazon takeover of One Healthcare has ignited significant buzz around GLP-1 drugs – innovative treatments initially for diabetes but increasingly being in obesity. Several patients are desiring access these drugs, https://finance.yahoo.com/sectors/healthcare/articles/amazon-one-medical-glp-1-175100178.html